Caricamento...

Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high mortality rates. Several clinical trials and meta-analyses have determined that the use of pharmacological inhibitors of cyclooxygenase 2 (COX-2), the enzyme that catalyses the rate-limiting step in the synthe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Alicia M. Hidalgo-Estévez, Konstantinos Stamatakis, Marta Jiménez-Martínez, Ricardo López-Pérez, Manuel Fresno
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2020-04-01
Serie:Frontiers in Pharmacology
Soggetti:
Accesso online:https://www.frontiersin.org/article/10.3389/fphar.2020.00533/full
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !